Prefer to read in print? Subscribe for free here
If you would like to feature in the next issue of Pf Magazine, contact us here
Latest articles
Junk DNA affects inherited cancer risk: New research
A new study published in the British Journal of Cancer shows that inherited cancer risk is not only affected by mutations in key cancer...
Half of WHO-recommended policies to reduce chronic diseases are not put into practice
The first analysis of WHO-recommended policies to reduce chronic diseases finds that implementation is slowly improving, but on average just over half get no...
New global survey shows public perceptions of lung cancer
New global survey shows public perceptions of lung cancer and also highlights that people believe that prognoses for the disease are dire, and there...
Popular articles
Novartis highlights progress in R&D pipeline
Novartis is holding an investor event to provide a comprehensive overview of the company’s progress in advancing its R&D pipeline. Key highlights to be presented...
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Half of WHO-recommended policies to reduce chronic diseases are not put into practice
The first analysis of WHO-recommended policies to reduce chronic diseases finds that implementation is slowly improving, but on average just over half get no...
MSD’s new HIV-1 treatment approved for use on the NHS
MSD's new HIV-1 treatment has been approved for use on the NHS. MSD has announced that its new treatment for HIV-1 infection – doravirine...
Pharma in 2019: Has uncertainty led to pharma innovation and change?
As the year draws to a close, has uncertainty led to pharma innovation and change in 2019? Have we been in a Brexit-related stasis?...